Source link : https://www.newshealth.biz/health-news/debate-over-best-treatment-for-high-risk-pe-at-ers-2024/
VIENNA — The optimal course of treatment when managing acute, high-risk pulmonary embolism (PE) remains a contentious topic among respiratory specialists. Systemic thrombolysis, specifically using recombinant tissue plasminogen activator (rtPA), is the current gold standard treatment for high-risk PE. However, the real-world application is less straightforward due to patient complexities. Some clinicians believe that advances […]
Author : News Health
Publish date : 2024-09-08 16:53:47
Copyright for syndicated content belongs to the linked Source.